Compounded Semaglutide: Cost, Safety, and How to Access It

What Is Compounded Semaglutide?

Semaglutide is the active ingredient in two widely known brand-name medications: Ozempic® (FDA-approved for type 2 diabetes) and Wegovy® (FDA-approved for chronic weight management), both manufactured by Novo Nordisk. It is a GLP-1 receptor agonist — a class of medications that mimic a gut hormone involved in appetite control, insulin regulation, and fat metabolism.

Compounded semaglutide is a customized preparation of the medication made by a state-licensed compounding pharmacy in response to a valid prescription from a licensed provider. It is different from FDA-approved branded products such as Wegovy® and Ozempic® and has not been evaluated by the FDA for safety, efficacy, or quality. Formulation, inactive ingredients, and clinical effects may differ from the FDA-approved branded versions.

Why Does Compounded Semaglutide Exist?

Federal law permits state-licensed compounding pharmacies to prepare customized versions of a medication when that medication appears on the FDA's drug shortage list. Semaglutide appeared on and remained on the shortage list for an extended period as demand — driven by clinical effectiveness and widespread media coverage — outpaced Novo Nordisk's manufacturing capacity. This opened a legal pathway for licensed compounding pharmacies to meet patient demand.

Beyond availability, cost has been the primary driver. Without insurance, brand-name Wegovy® and Ozempic® can cost $1,000 or more per month. For the majority of Americans without qualifying insurance coverage, compounded semaglutide has been the primary route to access.

How Effective Is Semaglutide for Weight Loss?

Semaglutide is one of the most well-studied weight-loss medications in history. The landmark STEP trials (published in the New England Journal of Medicine) showed:

• STEP 1: Adults with obesity (without type 2 diabetes) lost an average of 14.9% of body weight over 68 weeks on 2.4 mg semaglutide versus 2.4% with placebo.
• STEP 3: When combined with an intensive behavioral intervention, average weight loss reached 16% of body weight.
• For a 200-lb person, 14.9% represents approximately 30 lbs of average weight loss. Individual results may vary.

While tirzepatide — the active ingredient in Mounjaro® and Zepbound® — has shown higher average weight loss in trials, semaglutide remains a highly effective option with a well-documented safety profile and years of clinical experience. See our semaglutide vs tirzepatide comparison for a full head-to-head.

How Does It Work?

Semaglutide activates GLP-1 receptors throughout the body, producing several overlapping effects that reduce caloric intake:

• Appetite suppression: GLP-1 receptors in the hypothalamus regulate hunger signals. Activating them reduces appetite and increases the sensation of fullness between meals.
• Slowed gastric emptying: Food moves more slowly from the stomach to the small intestine, prolonging the feeling of satiety after eating and blunting blood sugar spikes.
• Reduced food noise: Many patients report a significant decrease in the mental preoccupation with food and cravings for high-calorie foods — an effect often described as "food noise going quiet."

Safety and Quality: What to Know About Compounded Semaglutide

Because compounded semaglutide is not FDA-approved, the question of quality and safety standards is important. The key protections for patients come from:

State-Licensed Compounding Pharmacies

Compounding pharmacies in the United States are regulated by state pharmacy boards and must comply with USP Chapter <797> standards for sterile compounding. Some pharmacies hold additional accreditation from organizations such as PCAB (the Pharmacy Compounding Accreditation Board), which requires independent quality testing and facility audits.

Licensed Provider Oversight

Compounded semaglutide requires a valid prescription from a licensed healthcare provider. A thorough telehealth provider — like AvataCore — conducts a clinical intake, reviews your medical history, confirms appropriate candidacy, and monitors your progress throughout treatment. This clinical layer is essential.

Excipients and Formulation

Compounded semaglutide preparations may use different inactive ingredients than the FDA-approved branded versions. Some formulations use bacteriostatic water as a diluent; others may include added vitamins or amino acids. The base molecule is semaglutide, but patients should ask their provider to explain exactly what is in their preparation. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality.

What Does Compounded Semaglutide Cost?

Cost varies by provider and dose, but compounded semaglutide through telehealth providers typically runs $150–$350 per month — a significant reduction from brand-name Wegovy® or Ozempic® prices. AvataCore offers GLP-1 programs starting at accessible introductory pricing. See AvataCore pricing → for current plans and details.

If you have insurance coverage for Wegovy or Ozempic, it is worth checking whether the brand-name is covered before defaulting to the compounded route. For those without coverage, the cost difference makes compounded semaglutide the primary realistic option. For a full cost breakdown across all semaglutide pathways, see our semaglutide cost guide.

Who Is a Good Candidate?

The FDA-approved Wegovy label is designed for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition (such as high blood pressure, type 2 diabetes, or high cholesterol). Providers prescribing compounded semaglutide generally apply the same clinical criteria. You should also have no personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, as these are contraindications.

A thorough clinical intake — which is part of the AvataCore process — screens for these factors and ensures compounded semaglutide is appropriate for your health profile. Read more about how to assess your eligibility in our GLP-1 candidacy guide.

How to Access Compounded Semaglutide Through AvataCore

The process is straightforward:

• Step 1: Complete a free medical assessment. Answer questions about your health history, current medications, and weight-loss goals. Our clinical team reviews your information.
• Step 2: Connect with a licensed provider. A provider reviews your case, addresses questions, and writes a prescription if you are a candidate.
• Step 3: Prescription sent to the compounding pharmacy. Your medication is prepared and shipped directly to you, typically within a few days.
• Step 4: Ongoing monitoring. Your provider checks in as you progress through the titration schedule and adjusts your dose as needed. See our guide to GLP-1 side effects to know what to expect during the adjustment period.

The Bottom Line

Compounded semaglutide exists because brand-name GLP-1 medications are priced beyond reach for the majority of patients who need them. It offers access to the same active ingredient — semaglutide — at significantly lower cost, through a state-licensed pharmacy under medical supervision. It is not FDA-approved and has not been evaluated by the FDA for safety, efficacy, or quality. Working with a reputable telehealth provider that conducts proper clinical intake and ongoing monitoring is essential. Compounded medications are not FDA-approved.